KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Deferred Taxes: 2009-2025

Historic Deferred Taxes for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $25.9 million.

  • Charles River Laboratories International's Deferred Taxes rose 300.60% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.6 million, marking a year-over-year decrease of 16.29%. This contributed to the annual value of -$67.4 million for FY2024, which is 32.46% down from last year.
  • Per Charles River Laboratories International's latest filing, its Deferred Taxes stood at $25.9 million for Q3 2025, which was up 217.82% from -$22.0 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Deferred Taxes high stood at $25.9 million for Q3 2025, and its period low was -$41.4 million during Q4 2024.
  • Moreover, its 3-year median value for Deferred Taxes was -$12.1 million (2024), whereas its average is -$12.1 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first soared by 477.25% in 2021, then plummeted by 1,829.18% in 2025.
  • Over the past 5 years, Charles River Laboratories International's Deferred Taxes (Quarterly) stood at -$10.2 million in 2021, then rose by 6.71% to -$9.6 million in 2022, then tumbled by 136.92% to -$22.7 million in 2023, then plummeted by 82.94% to -$41.4 million in 2024, then surged by 300.60% to $25.9 million in 2025.
  • Its Deferred Taxes was $25.9 million in Q3 2025, compared to -$22.0 million in Q2 2025 and -$19.0 million in Q1 2025.